Uncovering Potential Securities Fraud: Levi and Korsinsky Investigate Atara Biotherapeutics Inc. (ATRA)
Uncovering Potential Securities Fraud: Levi and Korsinsky Investigate Atara Biotherapeutics Inc. (ATRA) Description NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara Biotherapeutics, Inc. (“Atara Biotherapeutics, Inc.”) (NASDAQ:ATRA) concerning possible violations of federal securities laws.